Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Levodopa-Treated Parkinson's Disease
NCT05492019Phase 2Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jul 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in Parkinson's disease (PD), sponsored by Bangabandhu Sheikh Mujib Medical University. Status: unknown.
02
Drugs
doxycycline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05492019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05492019.